Table 3.
Recent progress in PA and MIR combined spectroscopy for glucose detection.
Date | Reference | Source | Wavenumber (cm) | Samples | G. conc. (mg/dL) | Correlation or Sensitivity | M.L. | Main Contributions |
---|---|---|---|---|---|---|---|---|
2005 | Toal et al. [20] | QCL | P:1080 Bg:1066 | Forearm | 0–300 | R = 0.61 | No | The PA and MIR combination |
2012 | Kottmann et al. [21] | QCL | P:1034 | Epidermal samples | 0–2000 | mg/dL | No | Using tunable QCLs and N ventilation |
2012 | Pleitez et al. [25] | EC-QCL | P:1054&1084 Bg:1100 | Palm | 80–260 | R = 0.70 | R.O. | Selecting three wavelengths |
2013 | Kottmann et al. [24] | EC-QCL | P:1034 | Glucose solution | 0–5000 | mg/dL | No | Fiber optics for light delivering |
2013 | Pleitez et al. [27] | EC-QCL | 1000–1220 | Hypothenar | 40–240 | - | R.O. | Removing noise by multivariate models |
2016 | Kottmann et al. [26] | EC-QCL | P:1080 Bg:1180 | Fingertip & forearm | 90–170 | mg/dL | R.O. | Stability improved by increasing pulse rate |
2017 | Sim et al. [28] | EC-QCL | 950–1245 | Fingertip & palm | 100–250 | 30% | R.O. | Studying skin effect on measurement |
G. conc.: glucose concentration, P: peak, Bg: background, R.O.: regression only.